AxoGen Inc reports results for the quarter ended December 31 - Earnings Summary

• AxoGen Inc AXGN.OQ reported quarterly adjusted earnings of 7 cents​​ per share for the quarter ended December 31, identical to the same quarter last year. The mean expectation of ten analysts for the quarter was for earnings of 10 cents per share. Wall Street expected results to range from 5 cents to 17 cents per share.

• Revenue rose 21.3% to $59.90 million from a year ago; analysts expected $59.11 million.

• AxoGen Inc's reported EPS for the quarter was 1 cent​.

• The company reported a quarterly loss of $13.16 million.

• AxoGen Inc shares had risen by 8.1% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 27% in the last three months.​

• In the last 30 days, there have been no negative revisions of earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 11 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"

• Wall Street's median 12-month price target for AxoGen Inc is $40.00, about 11.5% above its last closing price of $35.38

This summary was machine generated from LSEG data February 24 at 02:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)